Cargando…
Changes to hypothalamic volume and associated subunits during gender-affirming hormone therapy
BACKGROUND: Among its pleiotropic properties, gender-affirming hormone therapy (GHT) affects regional brain volumes. The hypothalamus, which regulates neuroendocrine function and associated emotional and cognitive processes, is an intuitive target for probing GHT effects. We sought to assess changes...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
CMA Impact Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521920/ https://www.ncbi.nlm.nih.gov/pubmed/37751919 http://dx.doi.org/10.1503/jpn.230017 |
_version_ | 1785110245994921984 |
---|---|
author | Konadu, Melisande E. Reed, Murray B. Kaufmann, Ulrike Handschuh, Patricia A. Spurny-Dworak, Benjamin Klöbl, Manfred Schmidt, Clemens Godber Godbersen, M. Briem, Elisa Seiger, René Baldinger-Melich, Pia Kranz, Georg S. Lanzenberger, Rupert Spies, Marie |
author_facet | Konadu, Melisande E. Reed, Murray B. Kaufmann, Ulrike Handschuh, Patricia A. Spurny-Dworak, Benjamin Klöbl, Manfred Schmidt, Clemens Godber Godbersen, M. Briem, Elisa Seiger, René Baldinger-Melich, Pia Kranz, Georg S. Lanzenberger, Rupert Spies, Marie |
author_sort | Konadu, Melisande E. |
collection | PubMed |
description | BACKGROUND: Among its pleiotropic properties, gender-affirming hormone therapy (GHT) affects regional brain volumes. The hypothalamus, which regulates neuroendocrine function and associated emotional and cognitive processes, is an intuitive target for probing GHT effects. We sought to assess changes to hypothalamus and hypothalamic subunit volumes after GHT, thereby honouring the region’s anatomical and functional heterogeneity. METHODS: Individuals with gender dysphoria and cisgender controls underwent 2 MRI measurements, with a median interval of 145 days (interquartile range [IQR] 128.25–169.75 d, mean 164.94 d) between the first and second MRI. Transgender women (TW) and transgender men (TM) underwent the first MRI before GHT and the second MRI after approximately 4.5 months of GHT, which comprised estrogen and anti-androgen therapy in TW or testosterone therapy in TM. Hypothalamic volumes were segmented using FreeSurfer, and effects of GHT were tested using repeated-measures analysis of covariance. RESULTS: The final sample included 106 participants: 38 TM, 15 TW, 32 cisgender women (CW) and 21 cisgender men (CM). Our analyses revealed group × time interaction effects for total, left and right hypothalamus volume, and for several subunits (left and right inferior tubular, left superior tubular, right anterior inferior, right anterior superior, all p(corr) < 0.01). In TW, volumes decreased between the first and second MRI in these regions (all p(corr) ≤ 0.01), and the change from the first to second MRI in TW differed significantly from that in CM and CW in several subunits (p(corr) < 0.05). LIMITATIONS: We did not address the influence of transition-related psychological and behavioural changes. CONCLUSION: Our results suggest a subunit-specific effect of GHT on hypothalamus volumes in TW. This finding is in accordance with previous reports of positive and negative effects of androgens and estrogens, respectively, on cerebral volumes. |
format | Online Article Text |
id | pubmed-10521920 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | CMA Impact Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-105219202023-09-27 Changes to hypothalamic volume and associated subunits during gender-affirming hormone therapy Konadu, Melisande E. Reed, Murray B. Kaufmann, Ulrike Handschuh, Patricia A. Spurny-Dworak, Benjamin Klöbl, Manfred Schmidt, Clemens Godber Godbersen, M. Briem, Elisa Seiger, René Baldinger-Melich, Pia Kranz, Georg S. Lanzenberger, Rupert Spies, Marie J Psychiatry Neurosci Research Paper BACKGROUND: Among its pleiotropic properties, gender-affirming hormone therapy (GHT) affects regional brain volumes. The hypothalamus, which regulates neuroendocrine function and associated emotional and cognitive processes, is an intuitive target for probing GHT effects. We sought to assess changes to hypothalamus and hypothalamic subunit volumes after GHT, thereby honouring the region’s anatomical and functional heterogeneity. METHODS: Individuals with gender dysphoria and cisgender controls underwent 2 MRI measurements, with a median interval of 145 days (interquartile range [IQR] 128.25–169.75 d, mean 164.94 d) between the first and second MRI. Transgender women (TW) and transgender men (TM) underwent the first MRI before GHT and the second MRI after approximately 4.5 months of GHT, which comprised estrogen and anti-androgen therapy in TW or testosterone therapy in TM. Hypothalamic volumes were segmented using FreeSurfer, and effects of GHT were tested using repeated-measures analysis of covariance. RESULTS: The final sample included 106 participants: 38 TM, 15 TW, 32 cisgender women (CW) and 21 cisgender men (CM). Our analyses revealed group × time interaction effects for total, left and right hypothalamus volume, and for several subunits (left and right inferior tubular, left superior tubular, right anterior inferior, right anterior superior, all p(corr) < 0.01). In TW, volumes decreased between the first and second MRI in these regions (all p(corr) ≤ 0.01), and the change from the first to second MRI in TW differed significantly from that in CM and CW in several subunits (p(corr) < 0.05). LIMITATIONS: We did not address the influence of transition-related psychological and behavioural changes. CONCLUSION: Our results suggest a subunit-specific effect of GHT on hypothalamus volumes in TW. This finding is in accordance with previous reports of positive and negative effects of androgens and estrogens, respectively, on cerebral volumes. CMA Impact Inc. 2023-09-26 /pmc/articles/PMC10521920/ /pubmed/37751919 http://dx.doi.org/10.1503/jpn.230017 Text en © 2023 CMA Impact Inc. or its licensors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/ |
spellingShingle | Research Paper Konadu, Melisande E. Reed, Murray B. Kaufmann, Ulrike Handschuh, Patricia A. Spurny-Dworak, Benjamin Klöbl, Manfred Schmidt, Clemens Godber Godbersen, M. Briem, Elisa Seiger, René Baldinger-Melich, Pia Kranz, Georg S. Lanzenberger, Rupert Spies, Marie Changes to hypothalamic volume and associated subunits during gender-affirming hormone therapy |
title | Changes to hypothalamic volume and associated subunits during gender-affirming hormone therapy |
title_full | Changes to hypothalamic volume and associated subunits during gender-affirming hormone therapy |
title_fullStr | Changes to hypothalamic volume and associated subunits during gender-affirming hormone therapy |
title_full_unstemmed | Changes to hypothalamic volume and associated subunits during gender-affirming hormone therapy |
title_short | Changes to hypothalamic volume and associated subunits during gender-affirming hormone therapy |
title_sort | changes to hypothalamic volume and associated subunits during gender-affirming hormone therapy |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521920/ https://www.ncbi.nlm.nih.gov/pubmed/37751919 http://dx.doi.org/10.1503/jpn.230017 |
work_keys_str_mv | AT konadumelisandee changestohypothalamicvolumeandassociatedsubunitsduringgenderaffirminghormonetherapy AT reedmurrayb changestohypothalamicvolumeandassociatedsubunitsduringgenderaffirminghormonetherapy AT kaufmannulrike changestohypothalamicvolumeandassociatedsubunitsduringgenderaffirminghormonetherapy AT handschuhpatriciaa changestohypothalamicvolumeandassociatedsubunitsduringgenderaffirminghormonetherapy AT spurnydworakbenjamin changestohypothalamicvolumeandassociatedsubunitsduringgenderaffirminghormonetherapy AT kloblmanfred changestohypothalamicvolumeandassociatedsubunitsduringgenderaffirminghormonetherapy AT schmidtclemens changestohypothalamicvolumeandassociatedsubunitsduringgenderaffirminghormonetherapy AT godber changestohypothalamicvolumeandassociatedsubunitsduringgenderaffirminghormonetherapy AT godbersenm changestohypothalamicvolumeandassociatedsubunitsduringgenderaffirminghormonetherapy AT briemelisa changestohypothalamicvolumeandassociatedsubunitsduringgenderaffirminghormonetherapy AT seigerrene changestohypothalamicvolumeandassociatedsubunitsduringgenderaffirminghormonetherapy AT baldingermelichpia changestohypothalamicvolumeandassociatedsubunitsduringgenderaffirminghormonetherapy AT kranzgeorgs changestohypothalamicvolumeandassociatedsubunitsduringgenderaffirminghormonetherapy AT lanzenbergerrupert changestohypothalamicvolumeandassociatedsubunitsduringgenderaffirminghormonetherapy AT spiesmarie changestohypothalamicvolumeandassociatedsubunitsduringgenderaffirminghormonetherapy |